Collection's Items (Sorted by Submit Date in Descending order): 21 to 40 of 78
| Preview | Issue Date | Title / Name | Author(s) |
| May-2015 | Management of castration-resistant (advanced) prostate cancer (CRPC): rationale, progress and future directions | Chopra, S.; Rashid, P.; Chopra, Sam; Rashid, Prem | |
| Apr-2005 | Clinical practice: review. Can we prevent prostate cancer? | Chong, P.; Rashid, P.; Rashid, Prem | |
| Jan-2012 | Prostatic urethral lift: two-year results after treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia | Chin, P. T.; Bolton, D. M.; Jack, G.; Rashid, P.; Thavaseelan, J.; Yu, R. J.; Roehrborn, C. G.; Woo, H. H.; Rashid, Prem | |
| Oct-2016 | Impact of branding on public awareness of healthcare‐related governing bodies: a pilot study of the Urological Society of Australia and New Zealand brand | Gianduzzo, T.R.J.; Gardiner, R.A.; Rashid, Prem; Young, R.; Frydenberg, M.; Kelly, S.; Rashid, Prem | |
| Jul-2008 | Post-prostatectomy radiation therapy: consensus guidelines of the Australian and New Zealand Radiation Oncology Genito-Urinary Group | Sidhom, M. A.; Kneebone, A. B.; Lehman, M.; Wiltshire, K. L.; Millar, J. L.; Mukherjee, R. K.; Shakespeare, T. P.; Tai, K. H.; Shakespeare, Thomas P. | |
| Sep-2023 | Prostate-specific membrane antigen positron emission tomography detected local failure after post-prostatectomy radiation therapy: Low rates of out-of-field recurrence validates current Australian prostate bed contouring guidelines | Shakespeare, T. P.; Yap, S. Z. L.; Hsieh, M.; Tahir, A. R. M.; Armstrong, S.; Shakespeare, Thomas P.; Yap, Shaun Z.; Hsieh, Michael; Tahir, Abdul R. M. | |
| Mar-2016 | Can we avoid dose escalation for intermediate-risk prostate cancer in the setting of short-course neoadjuvant androgen deprivation? | Shakespeare, T. P.; Wilcox, S. W.; Aherne, N. J.; Shakespeare, Thomas P.; Wilcox, Shea; Aherne, Noel | |
| May-2016 | Can we avoid high levels of dose escalation for high-risk prostate cancer in the setting of androgen deprivation? | Shakespeare, T. P.; Wilcox, S. W.; Aherne, N. J.; Shakespeare, Thomas P.; Wilcox, Shea; Aherne, Noel | |
| Mar-2020 | Choosing between conventional and hypofractionated prostate cancer radiation therapy: Results from a study of shared decision-making | Shakespeare, T. P.; Westhuyzen, J.; Fai, T. L. Y.; Aherne, N. J.; Shakespeare, Thomas P.; Westhuyzen, Justin; Aherne, Noel | |
| Dec-2019 | PSMA-PET guided dose-escalated volumetric arc therapy (VMAT) for newly diagnosed lymph node positive prostate cancer: Efficacy and toxicity outcomes at two years | Shakespeare, T. P.; Eggert, E.; Wood, M.; Westhuyzen, J.; Turnbull, K.; Rutherford, N.; Aherne, N.; Shakespeare, Thomas P.; Eggert, Elizabeth; Wood, Maree; Westhuyzen, Justin; Turnbull, Kirsty; Aherne, Noel | |
| Feb-2017 | Long-term decision regret after post-prostatectomy image-guided intensity-modulated radiotherapy | Shakespeare, T. P.; Chin, S.; Manuel, L.; Wen, S.; Hoffmann, M.; Wilcox, S. W.; Aherne, N. J.; Shakespeare, Thomas P.; Chin, Stephen; Hoffmann, Matthew; Wilcox, Shea; Aherne, Noel | |
| Oct-2016 | Long-Term Decision Regret After Postprostatectomy Image Guided Intensity Modulated Radiation Therapy | Shakespeare, T. P.; Chin, S.; Hoffmann, M.; Aherne, N.; Shakespeare, Thomas P.; Hoffmann, Matthew; Aherne, Noel | |
| Mar-2008 | Urinary incontinence-pathophysiology and management outline | Santiagu, S. K.; Arianayagam, M.; Wang, A.; Rashid, P.; Santiagu, Stanley K.; Arianayagam, Mohan; Rashid, Prem | |
| Oct-2016 | 24-month durability after crossover to the prostatic urethral lift from randomised, blinded sham | Rukstalis, D.; Rashid, P.; Bogache, W. K.; Tutrone, R. F.; Barkin, J.; Chin, P. T.; Woo, H. H.; Cantwell, A. L.; Cowan, B. E.; Bolton, D. M.; Rashid, Prem | |
| Dec-2013 | The prostatic urethral lift for the treatment of lower urinary tract symptoms associated with prostate enlargement due to benign prostatic hyperplasia: the L.I.F.T. Study | Roehrborn, C. G.; Gange, S. N.; Shore, N. D.; Giddens, J. L.; Bolton, D. M.; Cowan, B. E.; Brown, B. T.; McVary, K. T.; Te, A. E.; Gholami, S. S.; Rashid, P.; Moseley, W. G.; Chin, P. T.; Dowling, W. T.; Freedman, S. J.; Incze, P. F.; Coffield, K. S.; Borges, F. D.; Rukstalis, D. B.; Rashid, Prem | |
| Jun-2017 | Five year results of the prospective randomized controlled prostatic urethral L.I.F.T. study | Roehrborn, C. G.; Barkin, J.; Gange, S. N.; Shore, N. D.; Giddens, J. L.; Bolton, D. M.; Cowan, B. E.; Cantwell, A. L.; McVary, K. T.; Te, A. E.; Gholami, S. S.; Moseley, W. G.; Chin, P. T.; Dowling, W. T.; Freedman, S. J.; Incze, P. F.; Coffield, K. S.; Herron, S.; Rashid, P.; Rukstalis, D. B.; Rashid, Prem | |
| 2000 | Your prostate: questions answered. | Rashid, P.; Watters, G.; Rashid, Prem; Watters, Greg | |
| Nov-1996 | Splenic rupture after extracorporeal shock wave lithotripsy | Rashid, P.; Steele, D.; Hunt, J.; Rashid, Prem | |
| 2010 | Prostate cancer : your guide to the disease, treatment options and outcomes, 3rd Edition | Rashid, P.; Rashid, Prem | |
| Jan-2015 | Urology nSET 2016: fine tuning of the current programme | Rashid, P.; Grills, R.; Rashid, Prem | |
Collection's Items (Sorted by Submit Date in Descending order): 21 to 40 of 78